Resmed (RSMDF) Total Current Liabilities (2010 - 2026)

Resmed has reported Total Current Liabilities for 17 years, with the latest figure at $1.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 43.67% year-over-year to $1.4 billion; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (up 43.67% YoY), and the FY2025 full-year result was $1.0 billion, up 11.91% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $1.4 billion, up from $1.2 billion in the prior quarter.
• The five-year high for Total Current Liabilities was $1.4 billion in Q1 2026, with the low at $667.3 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $887.7 million across 5 years, with a median of $773.0 million in 2024.
• Annual changes were most pronounced in 2022 — Total Current Liabilities fell 24.4% — and 2025, when it jumped 46.5%.
• Resmed's Total Current Liabilities stood at $732.7 million in 2022, then advanced by 4.28% to $764.1 million in 2023, then gained by 11.5% to $852.0 million in 2024, then soared by 46.5% to $1.2 billion in 2025, then rose by 8.26% to $1.4 billion in 2026.
• The last three Total Current Liabilities figures came in at $1.4 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.